Literature DB >> 11927947

Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice.

Siri Atma W Greeley1, Makoto Katsumata, Liping Yu, George S Eisenbarth, Daniel J Moore, Heidi Goodarzi, Clyde F Barker, Ali Naji, Hooman Noorchashm.   

Abstract

The influence of maternally transmitted immunoglobulins on the development of autoimmune diabetes mellitus in genetically susceptible human progeny remains unknown. Given the presence of islet beta cell-reactive autoantibodies in prediabetic nonobese diabetic (NOD) mice, we abrogated the maternal transmission of such antibodies in order to assess their influence on the susceptibility of progeny to diabetes. First, we used B cell-deficient NOD mothers to eliminate the transmission of maternal immunoglobulins. In a complementary approach, we used immunoglobulin transgenic NOD mothers to exclude autoreactive specificities from the maternal B-cell repertoire. Finally, we implanted NOD embryos in pseudopregnant mothers of a non-autoimmune strain. The NOD progeny in all three groups were protected from spontaneous diabetes. These findings demonstrate that the maternal transmission of antibodies is a critical environmental parameter influencing the ontogeny of T cell-mediated destruction of islet beta cells in NOD mice. It will be important to definitively determine whether the transmission of maternal autoantibodies in humans affects diabetes progression in susceptible offspring.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11927947     DOI: 10.1038/nm0402-399

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  61 in total

1.  Can maternal microchimeric cells influence the fetal response toward self antigens?

Authors:  Lucie Leveque; Kiarash Khosrotehrani
Journal:  Chimerism       Date:  2011-07-01

Review 2.  Genetics, pathogenesis and clinical interventions in type 1 diabetes.

Authors:  Jeffrey A Bluestone; Kevan Herold; George Eisenbarth
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

3.  Enhanced anti-serpin antibody activity inhibits autoimmune inflammation in type 1 diabetes.

Authors:  Jan Czyzyk; Octavian Henegariu; Paula Preston-Hurlburt; Raman Baldzizhar; Christine Fedorchuk; Enric Esplugues; Kim Bottomly; Frans K Gorus; Kevan Herold; Richard A Flavell
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

Review 4.  Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal.

Authors:  B O Roep; M Atkinson
Journal:  Diabetologia       Date:  2004-10-13       Impact factor: 10.122

5.  The postnatal maternal environment influences diabetes development in nonobese diabetic mice.

Authors:  L R Washburn; H Dang; J Tian; D L Kaufman
Journal:  J Autoimmun       Date:  2007-01-04       Impact factor: 7.094

Review 6.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

7.  Ecological and life-history factors influencing the evolution of maternal antibody allocation: a phylogenetic comparison.

Authors:  Brianne Addison; Kirk C Klasing; W Douglas Robinson; Suzanne H Austin; Robert E Ricklefs
Journal:  Proc Biol Sci       Date:  2009-08-26       Impact factor: 5.349

Review 8.  Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases.

Authors:  C Hu; F S Wong; L Wen
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

9.  The elusive role of B lymphocytes and islet autoantibodies in (human) type 1 diabetes.

Authors:  Stef J Bloem; Bart O Roep
Journal:  Diabetologia       Date:  2017-04-24       Impact factor: 10.122

10.  Disentangling prenatal and inherited influences in humans with an experimental design.

Authors:  Frances Rice; Gordon T Harold; Jacky Boivin; Dale F Hay; Marianne van den Bree; Anita Thapar
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.